NCT05649475View on ClinicalTrials.gov

Circulating Tumor DNA Monitoring in Breast Cancer Undergoing Neoadjuvant Therapy

UnknownOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2021

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2025

Conditions
Stage I-III Breast Cancer
Trial Locations (1)

Unknown

RECRUITING

2nd Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou

Sponsors
All Listed Sponsors
collaborator

GeneCast Biotechnology Co., Ltd.

INDUSTRY

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT05649475 - Circulating Tumor DNA Monitoring in Breast Cancer Undergoing Neoadjuvant Therapy | Biotech Hunter | Biotech Hunter